APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Globulin Intravenous

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immune Globulin Intravenous Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchImmune Globulin Intravenous Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Globulin Intravenous Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Immune Globulin Intravenous Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Globulin Intravenous Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Globulin Intravenous Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Immune Globulin Intravenous market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immune Globulin Intravenous is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immune Globulin Intravenous include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immune Globulin Intravenous market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune Globulin Intravenous and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune Globulin Intravenous sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immune Globulin Intravenous market size, projected growth trends, production technologies, key applications, and end-use industries.

Immune Globulin Intravenous Segment by Company

Takeda

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CNBG

CBPO

BPL

Biotest

Immune Globulin Intravenous Segment by Type

IVIg Liquid

IVIg Powder

Immune Globulin Intravenous Segment by Application

Acute Infection

Immunodeficiency

Autoimmune Disease

Immune Globulin Intravenous Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Globulin Intravenous market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Globulin Intravenous and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Globulin Intravenous.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immune Globulin Intravenous market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immune Globulin Intravenous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Immune Globulin Intravenous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Immune Globulin Intravenous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Immune Globulin Intravenous Industry Trends Table 2. Immune Globulin Intravenous Industry Drivers Table 3. Immune Globulin Intravenous Industry Opportunities and Challenges Table 4. Immune Globulin Intravenous Industry Restraints Table 5. Global Immune Globulin Intravenous Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Immune Globulin Intravenous Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Immune Globulin Intravenous Sales by Manufacturers (units) & (2021-2026) Table 8. Global Immune Globulin Intravenous Sales Market Share by Manufacturers Table 9. Global Immune Globulin Intravenous Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Immune Globulin Intravenous Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Immune Globulin Intravenous Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Immune Globulin Intravenous Manufacturers, Product Type & Application Table 13. Global Immune Globulin Intravenous Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Immune Globulin Intravenous by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IVIg Liquid Table 17. Major Manufacturers of IVIg Powder Table 18. Global Immune Globulin Intravenous Sales by Type 2021 VS 2025 VS 2032 (units) Table 19. Global Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 20. Global Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 21. Global Immune Globulin Intravenous Sales Market Share by Type (2021-2026) Table 22. Global Immune Globulin Intravenous Sales Market Share by Type (2027-2032) Table 23. Global Immune Globulin Intravenous Revenue by Type 2021 VS 2025 VS 2032 (units) Table 24. Global Immune Globulin Intravenous Revenue by Type (2021-2026) & (units) Table 25. Global Immune Globulin Intravenous Revenue by Type (2027-2032) & (units) Table 26. Global Immune Globulin Intravenous Revenue Market Share by Type (2021-2026) Table 27. Global Immune Globulin Intravenous Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Acute Infection Table 29. Major Manufacturers of Immunodeficiency Table 30. Major Manufacturers of Autoimmune Disease Table 31. Global Immune Globulin Intravenous Sales by Application 2021 VS 2025 VS 2032 (units) Table 32. Global Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 33. Global Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 34. Global Immune Globulin Intravenous Sales Market Share by Application (2021-2026) Table 35. Global Immune Globulin Intravenous Sales Market Share by Application (2027-2032) Table 36. Global Immune Globulin Intravenous Revenue by Application 2021 VS 2025 VS 2032 (units) Table 37. Global Immune Globulin Intravenous Revenue by Application (2021-2026) & (units) Table 38. Global Immune Globulin Intravenous Revenue by Application (2027-2032) & (units) Table 39. Global Immune Globulin Intravenous Revenue Market Share by Application (2021-2026) Table 40. Global Immune Globulin Intravenous Revenue Market Share by Application (2027-2032) Table 41. Global Immune Globulin Intravenous Sales by Region: 2021 VS 2025 VS 2032 (units) Table 42. Global Immune Globulin Intravenous Sales by Region (2021-2026) & (units) Table 43. Global Immune Globulin Intravenous Sales Market Share by Region (2021-2026) Table 44. Global Immune Globulin Intravenous Sales Forecasted by Region (2027-2032) & (units) Table 45. Global Immune Globulin Intravenous Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 47. North America Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 48. North America Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 49. Europe Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 50. Europe Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 51. Europe Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 52. Asia Pacific Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 53. Asia Pacific Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 54. Asia Pacific Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 55. South America, Middle East and Africa Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 56. South America, Middle East and Africa Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 57. South America, Middle East and Africa Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 58. Global Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Immune Globulin Intravenous Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Immune Globulin Intravenous Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Immune Globulin Intravenous Revenue Market Share by Region (2021-2026) Table 62. Global Immune Globulin Intravenous Revenue Market Share by Region (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Immune Globulin Intravenous Product Portfolio Table 67. Takeda Recent Development Table 68. Sichuan Yuanda Shuyang Company Information Table 69. Sichuan Yuanda Shuyang Business Overview Table 70. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio Table 72. Sichuan Yuanda Shuyang Recent Development Table 73. Shanghai RAAS Company Information Table 74. Shanghai RAAS Business Overview Table 75. Shanghai RAAS Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shanghai RAAS Immune Globulin Intravenous Product Portfolio Table 77. Shanghai RAAS Recent Development Table 78. Hualan Bio Company Information Table 79. Hualan Bio Business Overview Table 80. Hualan Bio Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hualan Bio Immune Globulin Intravenous Product Portfolio Table 82. Hualan Bio Recent Development Table 83. Octapharma Company Information Table 84. Octapharma Business Overview Table 85. Octapharma Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Octapharma Immune Globulin Intravenous Product Portfolio Table 87. Octapharma Recent Development Table 88. LFB Group Company Information Table 89. LFB Group Business Overview Table 90. LFB Group Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. LFB Group Immune Globulin Intravenous Product Portfolio Table 92. LFB Group Recent Development Table 93. Kedrion Company Information Table 94. Kedrion Business Overview Table 95. Kedrion Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kedrion Immune Globulin Intravenous Product Portfolio Table 97. Kedrion Recent Development Table 98. Grifols Company Information Table 99. Grifols Business Overview Table 100. Grifols Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Grifols Immune Globulin Intravenous Product Portfolio Table 102. Grifols Recent Development Table 103. CSL Company Information Table 104. CSL Business Overview Table 105. CSL Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. CSL Immune Globulin Intravenous Product Portfolio Table 107. CSL Recent Development Table 108. CNBG Company Information Table 109. CNBG Business Overview Table 110. CNBG Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CNBG Immune Globulin Intravenous Product Portfolio Table 112. CNBG Recent Development Table 113. CBPO Company Information Table 114. CBPO Business Overview Table 115. CBPO Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CBPO Immune Globulin Intravenous Product Portfolio Table 117. CBPO Recent Development Table 118. BPL Company Information Table 119. BPL Business Overview Table 120. BPL Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. BPL Immune Globulin Intravenous Product Portfolio Table 122. BPL Recent Development Table 123. Biotest Company Information Table 124. Biotest Business Overview Table 125. Biotest Immune Globulin Intravenous Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Biotest Immune Globulin Intravenous Product Portfolio Table 127. Biotest Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Immune Globulin Intravenous Distributors List Table 131. Immune Globulin Intravenous Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Immune Globulin Intravenous Product Image Figure 2. Global Immune Globulin Intravenous Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Globulin Intravenous Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune Globulin Intravenous Sales (2021-2032) & (units) Figure 5. Global Immune Globulin Intravenous Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Immune Globulin Intravenous Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IVIg Liquid Image Figure 9. IVIg Powder Image Figure 10. Global Immune Globulin Intravenous Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 11. Global Immune Globulin Intravenous Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Immune Globulin Intravenous Sales Market Share by Type (2021-2032) Figure 13. Global Immune Globulin Intravenous Revenue by Type (2021 VS 2025 VS 2032) & (units) Figure 14. Global Immune Globulin Intravenous Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Immune Globulin Intravenous Revenue Market Share by Type (2021-2032) Figure 16. Acute Infection Image Figure 17. Immunodeficiency Image Figure 18. Autoimmune Disease Image Figure 19. Global Immune Globulin Intravenous Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 20. Global Immune Globulin Intravenous Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Immune Globulin Intravenous Sales Market Share by Application (2021-2032) Figure 22. Global Immune Globulin Intravenous Revenue by Application (2021 VS 2025 VS 2032) & (units) Figure 23. Global Immune Globulin Intravenous Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Immune Globulin Intravenous Revenue Market Share by Application (2021-2032) Figure 25. North America Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 26. North America Immune Globulin Intravenous Sales Market Share by Country (2021-2032) Figure 27. U.S. Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 28. Canada Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 29. Mexico Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 30. Europe Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 31. Europe Immune Globulin Intravenous Sales Market Share by Country (2021-2032) Figure 32. Germany Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 33. France Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 34. U.K. Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 35. Italy Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 36. Netherlands Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 37. Asia Pacific Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 38. Asia Pacific Immune Globulin Intravenous Sales Market Share by Country (2021-2032) Figure 39. China Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 40. Japan Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 41. South Korea Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 42. Southeast Asia Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 43. India Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 44. Australia Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 45. South America, Middle East and Africa Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 46. South America, Middle East and Africa Immune Globulin Intravenous Sales Market Share by Country (2021-2032) Figure 47. Brazil Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 48. South Africa Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 49. Saudi Arabia Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 50. Turkey Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 51. Argentina Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 52. UAE Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 53. Egypt Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 54. Chile Immune Globulin Intravenous Sales and Growth Rate (2021-2032) & (units) Figure 55. Global Immune Globulin Intravenous Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Immune Globulin Intravenous Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Figure 58. North America Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Figure 60. Europe Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Immune Globulin Intravenous Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Immune Globulin Intravenous Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Acute Infection
  • Immunodeficiency
  • Autoimmune Disease
Companies covered
  • Takeda
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immune Globulin Intravenous Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immune Globulin Intravenous Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Immune Globulin Intravenous Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Immune Globulin Intravenous Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Immune Globulin Intravenous Market Dynamics
  1. 2.1 Immune Globulin Intravenous Industry Trends
  2. 2.2 Immune Globulin Intravenous Industry Drivers
  3. 2.3 Immune Globulin Intravenous Industry Opportunities and Challenges
  4. 2.4 Immune Globulin Intravenous Industry Restraints
3 Immune Globulin Intravenous Market by Manufacturers
  1. 3.1 Global Immune Globulin Intravenous Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Immune Globulin Intravenous Sales by Manufacturers (2021-2026)
  3. 3.3 Global Immune Globulin Intravenous Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Immune Globulin Intravenous Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immune Globulin Intravenous Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Immune Globulin Intravenous Manufacturers, Product Type & Application
  7. 3.7 Global Immune Globulin Intravenous Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immune Globulin Intravenous Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immune Globulin Intravenous Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immune Globulin Intravenous Tier 1, Tier 2, and Tier 3
4 Immune Globulin Intravenous Market by Type
  1. 4.1 Immune Globulin Intravenous Type Introduction
  2. 4.1.1 IVIg Liquid
  3. 4.1.2 IVIg Powder
  4. 4.2 Global Immune Globulin Intravenous Sales by Type
  5. 4.2.1 Global Immune Globulin Intravenous Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Immune Globulin Intravenous Sales by Type (2021-2032)
  7. 4.2.3 Global Immune Globulin Intravenous Sales Market Share by Type (2021-2032)
  8. 4.3 Global Immune Globulin Intravenous Revenue by Type
  9. 4.3.1 Global Immune Globulin Intravenous Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Immune Globulin Intravenous Revenue by Type (2021-2032)
  11. 4.3.3 Global Immune Globulin Intravenous Revenue Market Share by Type (2021-2032)
5 Immune Globulin Intravenous Market by Application
  1. 5.1 Immune Globulin Intravenous Application Introduction
  2. 5.1.1 Acute Infection
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Autoimmune Disease
  5. 5.2 Global Immune Globulin Intravenous Sales by Application
  6. 5.2.1 Global Immune Globulin Intravenous Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immune Globulin Intravenous Sales by Application (2021-2032)
  8. 5.2.3 Global Immune Globulin Intravenous Sales Market Share by Application (2021-2032)
  9. 5.3 Global Immune Globulin Intravenous Revenue by Application
  10. 5.3.1 Global Immune Globulin Intravenous Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Immune Globulin Intravenous Revenue by Application (2021-2032)
  12. 5.3.3 Global Immune Globulin Intravenous Revenue Market Share by Application (2021-2032)
6 Global Immune Globulin Intravenous Sales by Region
  1. 6.1 Global Immune Globulin Intravenous Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune Globulin Intravenous Sales by Region (2021-2032)
  3. 6.2.1 Global Immune Globulin Intravenous Sales by Region (2021-2026)
  4. 6.2.2 Global Immune Globulin Intravenous Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Immune Globulin Intravenous Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Immune Globulin Intravenous Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Immune Globulin Intravenous Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Immune Globulin Intravenous Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Immune Globulin Intravenous Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Immune Globulin Intravenous Revenue by Region
  1. 7.1 Global Immune Globulin Intravenous Revenue by Region
  2. 7.1.1 Global Immune Globulin Intravenous Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Immune Globulin Intravenous Revenue by Region (2021-2026)
  4. 7.1.3 Global Immune Globulin Intravenous Revenue by Region (2027-2032)
  5. 7.1.4 Global Immune Globulin Intravenous Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Immune Globulin Intravenous Revenue (2021-2032)
  8. 7.2.2 North America Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Immune Globulin Intravenous Revenue (2021-2032)
  11. 7.3.2 Europe Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Immune Globulin Intravenous Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Immune Globulin Intravenous Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Immune Globulin Intravenous Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Immune Globulin Intravenous Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sichuan Yuanda Shuyang
  8. 8.2.1 Sichuan Yuanda Shuyang Company Information
  9. 8.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 8.2.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolio
  12. 8.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 8.3 Shanghai RAAS
  14. 8.3.1 Shanghai RAAS Company Information
  15. 8.3.2 Shanghai RAAS Business Overview
  16. 8.3.3 Shanghai RAAS Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai RAAS Immune Globulin Intravenous Product Portfolio
  18. 8.3.5 Shanghai RAAS Recent Developments
  19. 8.4 Hualan Bio
  20. 8.4.1 Hualan Bio Company Information
  21. 8.4.2 Hualan Bio Business Overview
  22. 8.4.3 Hualan Bio Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Bio Immune Globulin Intravenous Product Portfolio
  24. 8.4.5 Hualan Bio Recent Developments
  25. 8.5 Octapharma
  26. 8.5.1 Octapharma Company Information
  27. 8.5.2 Octapharma Business Overview
  28. 8.5.3 Octapharma Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Octapharma Immune Globulin Intravenous Product Portfolio
  30. 8.5.5 Octapharma Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group Immune Globulin Intravenous Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion Immune Globulin Intravenous Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 Grifols
  44. 8.8.1 Grifols Company Information
  45. 8.8.2 Grifols Business Overview
  46. 8.8.3 Grifols Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Grifols Immune Globulin Intravenous Product Portfolio
  48. 8.8.5 Grifols Recent Developments
  49. 8.9 CSL
  50. 8.9.1 CSL Company Information
  51. 8.9.2 CSL Business Overview
  52. 8.9.3 CSL Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CSL Immune Globulin Intravenous Product Portfolio
  54. 8.9.5 CSL Recent Developments
  55. 8.10 CNBG
  56. 8.10.1 CNBG Company Information
  57. 8.10.2 CNBG Business Overview
  58. 8.10.3 CNBG Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CNBG Immune Globulin Intravenous Product Portfolio
  60. 8.10.5 CNBG Recent Developments
  61. 8.11 CBPO
  62. 8.11.1 CBPO Company Information
  63. 8.11.2 CBPO Business Overview
  64. 8.11.3 CBPO Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CBPO Immune Globulin Intravenous Product Portfolio
  66. 8.11.5 CBPO Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 BPL Immune Globulin Intravenous Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Biotest
  74. 8.13.1 Biotest Company Information
  75. 8.13.2 Biotest Business Overview
  76. 8.13.3 Biotest Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biotest Immune Globulin Intravenous Product Portfolio
  78. 8.13.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immune Globulin Intravenous Value Chain Analysis
  2. 9.1.1 Immune Globulin Intravenous Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immune Globulin Intravenous Production Mode & Process
  6. 9.2 Immune Globulin Intravenous Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immune Globulin Intravenous Distributors
  9. 9.2.3 Immune Globulin Intravenous Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst